Catalyst Wire Dossier Catalyst Wire Dossier

r-hLIF

recombinant human leukemia inhibitory factor · Merck KGaA
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for r-hLIF, covering 2017-01-04 to 2017-01-04. Get the full timeline:

Most recent: Clinical Trial Update: r-hLIF for Improving Embryo Implantation in IVF [Phase 1, Phase 2]

See pricing